Comparative efficacy of two pyrethroid-piperonyl butoxide nets (Olyset Plus and PermaNet 3.0) against pyrethroid resistant malaria vectors: a non-inferiority assessment.
Anopheles
Benin
Cove
Cove Benin
Experimental huts
Insecticide resistance
Insecticide-treated nets
LLIN
Long-lasting insecticidal nets
Mixture
Next generation nets
Olyset
Olyset plus
PBO
PermaNet 3.0
Piperonyl butoxide
Pyrethroid resistance
Pyrethroid-PBO
Journal
Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802
Informations de publication
Date de publication:
11 Jan 2022
11 Jan 2022
Historique:
received:
20
05
2021
accepted:
03
01
2022
entrez:
12
1
2022
pubmed:
13
1
2022
medline:
27
1
2022
Statut:
epublish
Résumé
Pyrethroid-PBO nets were conditionally recommended for control of malaria transmitted by mosquitoes with oxidase-based pyrethroid-resistance based on epidemiological evidence of additional protective effect with Olyset Plus compared to a pyrethroid-only net (Olyset Net). Entomological studies can be used to assess the comparative performance of other brands of pyrethroid-PBO ITNs to Olyset Plus. An experimental hut trial was performed in Cové, Benin to compare PermaNet 3.0 (deltamethrin plus PBO on roof panel only) to Olyset Plus (permethrin plus PBO on all panels) against wild pyrethroid-resistant Anopheles gambiae sensu lato (s.l.) following World Health Organization (WHO) guidelines. Both nets were tested unwashed and after 20 standardized washes compared to Olyset Net. Laboratory bioassays were also performed to help explain findings in the experimental huts. With unwashed nets, mosquito mortality was higher in huts with PermaNet 3.0 compared to Olyset Plus (41% vs. 28%, P < 0.001). After 20 washes, mortality declined significantly with PermaNet 3.0 (41% unwashed vs. 17% after washing P < 0.001), but not with Olyset Plus (28% unwashed vs. 24% after washing P = 0.433); Olyset Plus induced significantly higher mortality than PermaNet 3.0 and Olyset Net after 20 washes. PermaNet 3.0 showed a higher wash retention of PBO compared to Olyset Plus. A non-inferiority analysis performed with data from unwashed and washed nets together using a margin recommended by the WHO, showed that PermaNet 3.0 was non-inferior to Olyset Plus in terms of mosquito mortality (25% with Olyset Plus vs. 27% with PermaNet 3.0, OR = 1.528, 95%CI = 1.02-2.29) but not in reducing mosquito feeding (25% with Olyset Plus vs. 30% with PermaNet 3.0, OR = 1.192, 95%CI = 0.77-1.84). Both pyrethroid-PBO nets were superior to Olyset Net. Olyset Plus outperformed PermaNet 3.0 in terms of its ability to cause greater margins of improved mosquito mortality compared to a standard pyrethroid net, after multiple standardized washes. However, using a margin of non-inferiority defined by the WHO, PermaNet 3.0 was non-inferior to Olyset Plus in inducing mosquito mortality. Considering the low levels of mortality observed and increasing pyrethroid-resistance in West Africa, it is unclear whether either of these nets would demonstrate the same epidemiological impact observed in community trials in East Africa.
Sections du résumé
BACKGROUND
BACKGROUND
Pyrethroid-PBO nets were conditionally recommended for control of malaria transmitted by mosquitoes with oxidase-based pyrethroid-resistance based on epidemiological evidence of additional protective effect with Olyset Plus compared to a pyrethroid-only net (Olyset Net). Entomological studies can be used to assess the comparative performance of other brands of pyrethroid-PBO ITNs to Olyset Plus.
METHODS
METHODS
An experimental hut trial was performed in Cové, Benin to compare PermaNet 3.0 (deltamethrin plus PBO on roof panel only) to Olyset Plus (permethrin plus PBO on all panels) against wild pyrethroid-resistant Anopheles gambiae sensu lato (s.l.) following World Health Organization (WHO) guidelines. Both nets were tested unwashed and after 20 standardized washes compared to Olyset Net. Laboratory bioassays were also performed to help explain findings in the experimental huts.
RESULTS
RESULTS
With unwashed nets, mosquito mortality was higher in huts with PermaNet 3.0 compared to Olyset Plus (41% vs. 28%, P < 0.001). After 20 washes, mortality declined significantly with PermaNet 3.0 (41% unwashed vs. 17% after washing P < 0.001), but not with Olyset Plus (28% unwashed vs. 24% after washing P = 0.433); Olyset Plus induced significantly higher mortality than PermaNet 3.0 and Olyset Net after 20 washes. PermaNet 3.0 showed a higher wash retention of PBO compared to Olyset Plus. A non-inferiority analysis performed with data from unwashed and washed nets together using a margin recommended by the WHO, showed that PermaNet 3.0 was non-inferior to Olyset Plus in terms of mosquito mortality (25% with Olyset Plus vs. 27% with PermaNet 3.0, OR = 1.528, 95%CI = 1.02-2.29) but not in reducing mosquito feeding (25% with Olyset Plus vs. 30% with PermaNet 3.0, OR = 1.192, 95%CI = 0.77-1.84). Both pyrethroid-PBO nets were superior to Olyset Net.
CONCLUSION
CONCLUSIONS
Olyset Plus outperformed PermaNet 3.0 in terms of its ability to cause greater margins of improved mosquito mortality compared to a standard pyrethroid net, after multiple standardized washes. However, using a margin of non-inferiority defined by the WHO, PermaNet 3.0 was non-inferior to Olyset Plus in inducing mosquito mortality. Considering the low levels of mortality observed and increasing pyrethroid-resistance in West Africa, it is unclear whether either of these nets would demonstrate the same epidemiological impact observed in community trials in East Africa.
Identifiants
pubmed: 35016676
doi: 10.1186/s12936-022-04041-9
pii: 10.1186/s12936-022-04041-9
pmc: PMC8753866
doi:
Substances chimiques
Pyrethrins
0
Piperonyl Butoxide
LWK91TU9AH
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
20Subventions
Organisme : Medical Research Council
ID : MR/L004437/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R015600/1
Pays : United Kingdom
Informations de copyright
© 2022. The Author(s).
Références
Malar J. 2018 Jan 18;17(1):39
pubmed: 29347953
Lancet. 2020 Apr 18;395(10232):1292-1303
pubmed: 32305094
Philos Trans R Soc Lond B Biol Sci. 2013 Jan 06;368(1612):20120429
pubmed: 23297352
Trends Parasitol. 2016 Mar;32(3):187-196
pubmed: 26826784
Med Vet Entomol. 2000 Mar;14(1):1-5
pubmed: 10759305
Elife. 2016 Aug 22;5:
pubmed: 27547988
Sci Rep. 2015 Sep 01;5:13392
pubmed: 26323965
PLoS Biol. 2020 Jun 25;18(6):e3000633
pubmed: 32584814
Parasit Vectors. 2019 Nov 15;12(1):544
pubmed: 31730481
Lancet. 2018 Apr 21;391(10130):1577-1588
pubmed: 29655496
Trop Med Int Health. 2002 Dec;7(12):1003-8
pubmed: 12460390
PLoS One. 2019 Dec 23;14(12):e0226191
pubmed: 31869350
Malar J. 2010 Jan 19;9:21
pubmed: 20085631
Malar J. 2015 Nov 18;14:464
pubmed: 26581678
Infect Dis Poverty. 2017 Jan 18;6(1):11
pubmed: 28095897
J Am Mosq Control Assoc. 2009 Jun;25(2):156-67
pubmed: 19653497
Trans R Soc Trop Med Hyg. 2010 Dec;104(12):758-65
pubmed: 20956008
Malar J. 2010 Apr 27;9:113
pubmed: 20423479
PLoS One. 2013 Oct 08;8(10):e75134
pubmed: 24116029